This event has now concluded.

The rate of tobacco use in PLWHIV is reported to be about 2 times the rate of the general community. Tobacco use is one of the most significant risk factors for comorbidity amongst PHWHIV. Success rates for smoking cessation have not been high using traditional techniques.

Agenda

6.15 pm: Arrival and Registration
6.30 pm: Start of meeting – Welcome and Introduction
6.40 pm: 1st Speaker – Chris Howard
7.00 pm: 2nd Speaker – Assoc Prof Colin Mendelsohn
7.50 pm: 3rd Speaker – Assoc. Prof. Coral Gartner
8.30 pm: Questions to the panel
Evaluation of the meeting
9.00 pm: Meeting close
(dinner will be served concurrently during the meeting)

Meeting highlights

• To reflect and build on the Queensland experience with smoking cessation programs in the HIV+ve community (QPP Positively Quitting Program)
• Up to date clinical and research data on effective techniques in smoking cessation.
• Practical recommendations on effective smoking cessation technique(s), inc. vaping
• To discuss the place of vaping (e-cigarettes) in harm reduction or cessation techniques
• Presentation of clinical and research findings of smoking cessation and vaping, with particular focus on the HIV+ve community
• Announcement of The Cessation and Relapse Prevention (CARP) Trial: HIV+ve Cohort

Speakers

1) Chris Howard

Queensland Positive People (QPP), Life+ Program Manager
Topic: Positively Quitting Program (Smoking cessation project in PLWHIV)

2) Associate Prof. Colin Mendelsohn

Smoking Cessation, what works and what doesn’t
Topic: Practical tips and techniques for successful smoking cessation. Update on Vaping and the use of electronic cigarettes for tobacco harm reduction and/or smoking cessation.

3) Associate Prof. Coral Gartner

Comparing the effectiveness, safety and cost-effectiveness of providing vaporised (inhaled) nicotine products to priority populations (PLWHIV) living with co-morbidities for the cessation of tobacco use, and the use of nicotine maintenance therapy for relapse prevention.